Study Details

Back
Study ID 1707-CL-3001
Study Title A randomized, placebo-controlled, double-blind, parallel group phase 2a study of ASP1707 in postmenopausal female patients with rheumatoid arthritis (RA) taking methotrexate (MTX)
Clinicaltrials.gov Identifier NCT02884635
Compound Name ASP1707
Medical Indication or Disease Rheumatoid arthritis
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 16-Sep-2016
Study Completion Date 25-Oct-2017
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS